Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate safety and efficacy of DE-114 ophthalmic solution
compared to its Placebo and Olopatadine hydrochloride 0.1% ophthalmic solution in patients
with allergic conjunctivitis.